miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2
Authors:
- 1 December 2020
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 53 (2) , 189-200
Abstract
MiR-195-5p has been widely explored in various cancers and is considered as a tumor-suppressive microRNA. However, its roles in human lung cancer pathogenesis are not fully elucidated. In this study, we aimed to explore how miR-195-5p is involved in malignant behaviors of lung adenocarcinoma (LUAD) cells. miR-195-5p expression was examined in the tumor tissues of patients with LUAD and human LUAD cell lines including A549 and PC-9. Thioredoxin reductase 2 (TrxR2) was predicted to be an mRNA target of miR-195-5p using online tools and validated by the Dual-Luciferase Reporter Assay. Lentivirus infection was used for gene overexpression, while gene knockdown was achieved by RNA interference. Cell proliferation was determined by Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine methods, and cell migration and invasion were assayed with transwell experiments. Cell apoptosis was determined by annexin V staining-based flow cytometry. The antitumor effects of miR-195-5p were also evaluated in nude mice xenografted with A549 cells. We found that miR-195-5p was lowly expressed in human LUAD cells, and its overexpression markedly suppressed cell proliferation, migration, and invasion and increased the apoptosis of LUAD cells in vitro. TrxR2 knockdown phenocopied the tumor-suppressive effects of miR-195-5p overexpression, while simultaneous TrxR2 overexpression remarkably reversed the effects of miR-195-5p overexpression on malignant behaviors of A549 and PC-9 cells. Additionally, miR-195-5p overexpression inhibited the growth of xenografted A549 tumor in nude mice. Our work verified that miR-195-5p exerts tumor-suppressive functions in LUAD cells through targeting TrxR2 and suggested that the miR-195-5p/TrxR2 axis is a potential biomarker for LUAD therapy.Keywords
Funding Information
- Xi’an Science and Technology Program (201805093YX1SF27(2))
- Shaanxi Key Research and Development Program (2019SF-208)
- National Natural Science Foundation of China (81672300)
This publication has 45 references indexed in Scilit:
- Circulating MicroRNAs in Relation to EGFR Status and Survival of Lung Adenocarcinoma in Female Non-SmokersPLOS ONE, 2013
- Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate CancerPLOS ONE, 2012
- Genetic Variation in Selenoprotein Genes, Lifestyle, and Risk of Colon and Rectal CancerPLOS ONE, 2012
- MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapyNature Reviews Cancer, 2011
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Targeting microRNAs in cancer: rationale, strategies and challengesNature Reviews Drug Discovery, 2010
- Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer: Suppression of Tumorigenic Property of Lung Cancer Cells and Their Sensitization to Doxorubicin-Induced Apoptosis by miR-1Journal of Biological Chemistry, 2008
- Lung Cancer in Never Smokers: A ReviewJournal of Clinical Oncology, 2007
- MicroRNAsCell, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001